We have analyzed the expression of the intracellular marker protein neuron specific enolase (NSE), synaptophysin (SYN) and of the cell surface marker NCAM (neural cell adhesion molecule) in both normal human hypophysis and in pituitary adenomas in order to explore their potential use as diagnostic tools. All adenomas (4 prolactinomas, 3 growth hormone (GH) producing adenomas and 4 inactive adenomas) showed SYN and NSE immunoreactivity on tissue sections and this was confirmed by immunoblots. NCAM 140 (an isoform of NCAM with molecular mass 140 kOa) was detected by immunoblotting in normal human adenohypophysis, in all GH adenomas, and in three out of four inactive adenomas, but not in prolactinomas. Using highly sensitive techniques, NCAM immunoreactivity was observed by electron microscopy in a1l adenomas. These data indicate that NCAM 140 is a constituent of the cell surface of endocrine cells in both normal human adenohypophysis and its tumors. Since prolactinomas express very low levels ofNCAM 140 compared to other hypophyseal tumors its virtual absence could be used for differential diagnosis. A combined analysis of NCAM, SYN and NSE could be useful to characterize inactive adenomas which are not immunoreactive for pituitary hormones and which may contain no or only low levels ofthe alpha chain ofthe glycoprotein hormones.
INTRODUCTION
Though widely dispersed in different tissues throughout the body, endocrine cells have many properties in common [1] , some of which are also shared with cells of the nervous system. Thus neuron specific enolase (NSE) first recognized in the central nervous system has since become a 'classical' marker for endocrine cells [2] . More recently, other intracellular proteins including synaptophysin (SYN), a constituent of secretory vesicles, and neural cell adhesion moleeule (NCAM), a family of moleeules which have been implicated in intercellular adhesion and neural histogenesis, have been shown to be shared by both neural and endocrine cells [3] [4] [5] [6] . The molecular and cell biology of these markers is weIl documented [7 -10] . The analysis of these more recently discovered proteins in human pituitary tumors represents an essential step in assessing potential applications in clinical diagnosis. In this study we report immunocytochemical and immunological data on NSE-, SYN-and NCAMexpression in various clinically and histochemically defined human adenomas which demonstrate the value of these moleeules as diagnostic markers.
MATERIALS AND METHODS

Tissues
11 surgically removed pituitary adenomas (prolactinoma, GH adenoma, hormonally inactive adenoma), I normal neurohypophysis and 2 normal adenohypophyses were investigated. For electrophoresis and immunoblotting the tissues were frozen in 0.5 M HCI immediately after excision. For immunocytochemical analysis of NCAM small tissue pieces were fixed immediately by immersion in freshly prepared phosphate-buffered paraformaldehyde (0.1 M, pH 7.2,4%) for 2-3 h at room temperature.
Immunocytochemistry
NCAM was detected by electron microscopy using the preembedding streptavidin-biotin method (11) or the indirect method as described previously [5, 6, 12) . Biotinylated donkey anti-rabbit immunoglobulin and peroxidase-streptavidin, obtained from Amersham, were used at dilutions recommended by the manufacturers. A polycIonal antibody (kindly provided by Or G. Rougon, Marseille, France) directed against the undecapeptide present at the aminoterminal of the mouse NCAM (dilution I: 1000 or I :2000) was employed (13) .
For detection of SYN, NSE, pituitary hormones and the alpha chain of the glycoprotein hormones the surgically resected adenomas were fixed in phosphate-buffered formaldehyde (4Il7o) and embedded in paraffin. The de-paraffinized sections were incubated with a polycIonal rabbit serum directed against rat synaptophysin (SYN, dilution 1: 1000; kindly provided by Or R. Jahn, Munich, FRG) and human neuron-specific enolase (NSE, dilution 1: 1000; Oakopatts, Copenhagen, Denmark). The immunoreaction was visualized by the indirect peroxidase-anti-peroxidase method [14) using reagents obtained from Dakopatts (Copenhagen, Oenmark). Immunocytochemical detection of prolactin (PRL), growth hormone (GH), corticotropin (ACTH) and alpha chain was carried out as described recently [15) .
E/ectrophoresis and immunob/otting
RESULTS AND DISCUSSION
Tissues were cut into small pieces and Iysed in extraction medium (62.5 mM Tris, 2% SDS, IOOJo sucrose, pH 6.8) by sonication. The Iysate was boiled for 5 min and centrifuged at 10000 x g. SDS-PAGE (7.5OJo) under reducing conditions (80-150)/g of protein/lane) and immunoblotting were performed as previously described [16] . Blots were incubated with antibodies directed against NCAM (dilution I: 1(00), SYN (dilution 1: 10(00) and NSE (dilution 1: 3(00). Since only small amounts of tissue were available the same nitrocellulose strips were first incubated with anti-NCAM antibody and then with anti-SYN antibody or anti-NSE antibody. Binding of antibodies was detected by iodinated protein A [16] .
Prolactinomas, GH adenomas and hormonally inactive adenomas comprise about 90!t7o of the pituitary tumors in man [15] . We have investigated the characteristic constituents of these frequent adenomas with different immunological techniques. The clinical features of the patients from which the tumors were removed by transphenoidal surgery (except case 5 in which the tumor was removed transcranially) are listed in Table I. 46 Recently we discovered that NCAM, originally thought to be confined in adults to the nervous system is present in rat endocrine cells including the adenohypophysis [5, 6] . The present study investigates whether human pituitary tumors also contain such molecules, and whether they could be employed as general markers of endocrine cells like NSE. As shown in Table 11 the prolactinomas and GH adenomas analyzed here contain NSE in addition to certain hormones. It is also present in the heterogeneous group of hormonally inactive adenomas.
Synaptophysin (SYN) first discovered in 1977 and named synaptin [17] and subsequently studied in- dependently under the names of P38 [3, 8] and synaptophysin [4, 7, 9] has been reported to occur in pituitary tumors which were not characterized further [18] . Using both immunocytochemistry and immunoblot analysis SYN was unambiguously demonstrated in all the types of pituitary tumors classified here (Table 11) . We may thus conclude that SYN, like NSE, can be used as a general marker for pituitary tumors. In particular the inactive adenomas, which are not immunoreactive for pituitary hormones and may show no or only weak staining for the alpha chain of the glycoprotein hormones (see cases 8, 9 and 11, Table 11 ) do express NSE and SYN. Thus NSE and SYN are valuable markers for identifying these neoplasms by immunological (Table  11 ) and immunocytochemical techniques (see Fig. 1 ). NCAM 140 is the only NCAM isoform detected in the normal human adenohypophysis, while the three isoforms of this family typical of nervous tissue proteins (NCAM 120, NCAM 140, NCAM 180) are present in the neural lobe of the hypophysis (Fig. 2) . This difference between neurohypophysis and adenohypophysis agrees with data obtained in the rat pituitary [6] . NCAM could not be detected in prolactinomas by immunoblotting but NCAM 140 was detectable using such techniques in GH adenomas and also in three out of four hormonally inactive adenomas (see Fig. 2 and Table 11 ). The apparent absence of NCAM in the prolactinomas reflects the limits of detection of these proteins by this method, since, by using sensitive immunocytochemical procedures, NCAM could be detected even in prolactinomas at the electron microscopicallevel (Fig. 3) . Prolactinomas stained less intensely but the distribution of the immunoreaction product in prolactinomas was indistinguishable from that seen in GH adenomas which contain sufficient NCAM 140 to be easily detected on immunoblots ( Fig. 2 and Table 11 ).
NCAM 140 was not detectable by immunoblotting in one hormonally inactive tumor (case 9, see Table 11 ). It is possible that this adenoma is in fact a prolactinoma in origin producing low levels of prolactin (which are undetectable by immunocytochemistry) but which, however, might be detectable with very sensitive 48 hybridization techniques with PRL mRNA probes [19}.
Both the histological features of this tumor ('burnt out tumor') and the apparent absence of NCAM 140 on immunoblots accord with this interpretation.
It is interesting to note that most hormonally inactive pituitary tumors also stain for chromogranin A (CGA) [20] . While prolactinomas do not appear to contain CGA, GH adenomas have been shown to express CGA [20] and more recently CGA mRNA has been demonstrated in GH adenomas [21] . This suggests that CGA is differentially expressed by pituitary adenomas in a similar way as NCAM 140.
In summary, immunological analysis of pituitary adenomas for NSE and SYN permits unambiguous identification of the endocrine nature of the tumor tissue. This is particularly important in about 20OJo of all adenomas which are hormonally inactive [15] and for which therefore hormones cannot be used as markers. Hormones, however, are valuable tools for the identification of both GH adenomas and prolactinomas. These adenomas can also be distinguished by their levels of CGA and NCAM 140. A practical feature of CGA is that it is a secretory product and thus may provide a functional marker for GH adenomas or for tumors that do not express hormones (inactive adenomas). Therefore CGA could be employed for these adenomas clinically as a serum marker, in a similar way as for other endocrine neoplasms [22, 23] .
We have demonstrated here that NCAM could also be used for immunohistochemical and immunochemical differential tumor diagnosis. A unique advantage of NCAM compared with the other intracellular markers such as NSE, SYN or CGA concerns its accessibility as a surface molecule. We suggest that antibodies against NCAM could be used for immunoscintigraphy, radiotherapy or targeting of drugs to adenoma cells. In conclusion, this investigation of the differential expression of NCAM in different pituitary tumors suggest that this marker may be added to the range of markers currently used for tumor diagnosis and in addition, may provide a possible route for their treatment. In this context it is interesting to note that NCAM has been recently detected in another frequent human endocrine tumor, the small cell lung carcinoma [24] [25] [26] [27] .
